Jump Trading Has Cut Its Biogen (Put) (BIIB) Stake by $686,400; Stock Value Declined; Valinor Management Stake in Carter (CRI) Has Trimmed by $29.18 Million

February 15, 2018 - By Louis Casey

David Gallo decreased its stake in Carter Inc (CRI) by 24.07% based on its latest 2017Q3 regulatory filing with the SEC. Valinor Management Llc sold 297,760 shares as the company’s stock declined 1.16% while stock markets rallied. The hedge fund run by David Gallo held 939,466 shares of the consumer non-durables company at the end of 2017Q3, valued at $92.77 million, down from 1.24M at the end of the previous reported quarter. Valinor Management Llc who had been investing in Carter Inc for a number of months, seems to be less bullish one the $5.79B market cap company. The stock increased 0.86% or $1.04 during the last trading session, reaching $122.29. About 110,980 shares traded. Carter's, Inc. (NYSE:CRI) has declined 16.63% since February 15, 2017 and is downtrending. It has underperformed by 33.33% the S&P500.

Jump Trading Llc decreased its stake in Biogen Inc (Put) (BIIB) by 75.86% based on its latest 2017Q3 regulatory filing with the SEC. Jump Trading Llc sold 2,200 shares as the company’s stock declined 13.45% while stock markets rallied. The institutional investor held 700 shares of the biological products (no diagnostic substances) company at the end of 2017Q3, valued at $219,000, down from 2,900 at the end of the previous reported quarter. Jump Trading Llc who had been investing in Biogen Inc (Put) for a number of months, seems to be less bullish one the $63.25B market cap company. The stock increased 0.97% or $2.86 during the last trading session, reaching $298.94. About 950,039 shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since February 15, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

Among 32 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 24 have Buy rating, 0 Sell and 8 Hold. Therefore 75% are positive. Biogen Idec Inc. had 111 analyst reports since July 23, 2015 according to SRatingsIntel. The firm earned “Overweight” rating on Monday, November 7 by PiperJaffray. As per Tuesday, January 16, the company rating was maintained by Canaccord Genuity. The rating was maintained by Mizuho with “Hold” on Sunday, October 15. The firm has “Hold” rating by BMO Capital Markets given on Thursday, June 1. The stock of Biogen Inc. (NASDAQ:BIIB) has “Buy” rating given on Tuesday, August 11 by H.C. Wainwright. The rating was maintained by RBC Capital Markets on Monday, July 27 with “Outperform”. The stock has “Hold” rating by Jefferies on Wednesday, August 30. Robert W. Baird maintained Biogen Inc. (NASDAQ:BIIB) on Thursday, September 28 with “Hold” rating. Stifel Nicolaus maintained the stock with “Hold” rating in Tuesday, July 25 report. Piper Jaffray maintained it with “Buy” rating and $407.0 target in Thursday, January 18 report.

Investors sentiment increased to 1.13 in Q3 2017. Its up 0.25, from 0.88 in 2017Q2. It is positive, as 59 investors sold BIIB shares while 283 reduced holdings. 96 funds opened positions while 292 raised stakes. 181.16 million shares or 0.28% more from 180.66 million shares in 2017Q2 were reported. 2,822 are held by Trexquant Invest Limited Partnership. Spears Abacus Advsr Ltd stated it has 0.27% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Fortaleza Asset Mgmt Inc invested in 1.51% or 2,630 shares. 725 were accumulated by Moors Cabot. North American Corporation, Massachusetts-based fund reported 725 shares. Pax Mngmt Limited Liability Corporation invested in 1.56% or 87,246 shares. Adage Cap Prns Grp Incorporated Ltd holds 245,369 shares or 0.19% of its portfolio. Citadel Advsr Ltd Co holds 0.16% or 663,696 shares. Amf Pensionsforsakring holds 0.79% in Biogen Inc. (NASDAQ:BIIB) or 232,061 shares. Vanguard Gp owns 14.67M shares for 0.21% of their portfolio. Clough Capital LP reported 52,672 shares or 1.11% of all its holdings. Moreover, Principal Fincl Grp Inc has 0.14% invested in Biogen Inc. (NASDAQ:BIIB) for 452,536 shares. Citigroup holds 0.07% or 282,859 shares in its portfolio. Moreover, Rathbone Brothers Public Ltd Co has 0.01% invested in Biogen Inc. (NASDAQ:BIIB) for 913 shares. United Kingdom-based Guinness Asset Limited has invested 0% in Biogen Inc. (NASDAQ:BIIB).

Jump Trading Llc, which manages about $553.48M US Long portfolio, upped its stake in Verizon Communications Inc (Call) (NYSE:VZ) by 12,800 shares to 36,100 shares, valued at $1.79M in 2017Q3, according to the filing. It also increased its holding in Priceline Group Inc/The (Put) (NASDAQ:PCLN) by 300 shares in the quarter, for a total of 400 shares, and has risen its stake in Spdr Dow Jones Industrial Average Etf Trust (Put) (DIA).

Since January 9, 2018, it had 0 buys, and 1 sale for $1.92 million activity.

Among 16 analysts covering Carter’s (NYSE:CRI), 10 have Buy rating, 1 Sell and 5 Hold. Therefore 63% are positive. Carter’s had 33 analyst reports since August 31, 2015 according to SRatingsIntel. The stock has “Hold” rating by Cowen & Co on Thursday, July 27. The rating was downgraded by Wells Fargo to “Market Perform” on Tuesday, September 27. Suntrust Robinson initiated Carter's, Inc. (NYSE:CRI) on Thursday, December 21 with “Hold” rating. FBR Capital maintained the stock with “Buy” rating in Tuesday, July 11 report. The stock of Carter's, Inc. (NYSE:CRI) earned “Hold” rating by Cowen & Co on Monday, October 23. The firm earned “Buy” rating on Friday, June 16 by FBR Capital. The firm earned “Neutral” rating on Wednesday, September 16 by Piper Jaffray. The firm has “Overweight” rating given on Wednesday, January 25 by Morgan Stanley. The stock has “Buy” rating by Oppenheimer on Tuesday, June 13. Oppenheimer upgraded it to “Outperform” rating and $108 target in Monday, January 4 report.

Analysts await Carter's, Inc. (NYSE:CRI) to report earnings on February, 22. They expect $2.20 EPS, up 22.91% or $0.41 from last year’s $1.79 per share. CRI’s profit will be $104.11 million for 13.90 P/E if the $2.20 EPS becomes a reality. After $1.70 actual EPS reported by Carter's, Inc. for the previous quarter, Wall Street now forecasts 29.41% EPS growth.

Valinor Management Llc, which manages about $4.82 billion and $3.19B US Long portfolio, upped its stake in Facebook Inc (NASDAQ:FB) by 71,200 shares to 858,575 shares, valued at $146.70M in 2017Q3, according to the filing. It also increased its holding in Transdigm Group Inc (NYSE:TDG) by 7,983 shares in the quarter, for a total of 435,246 shares, and has risen its stake in Envision Healthcare Corp.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Louis Casey

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: